Loading clinical trials...
Loading clinical trials...
A Phase II Study of Pemetrexed/Carboplatin/Radiotherapy and Bevacizumab in Patients With Unresectable Stage III Non-Small-Cell Lung Cancer
Conditions
Interventions
Bevacizumab
Pemetrexed
+4 more
Locations
7
United States
Gainsville Hematology Oncology Associates
Gainesville, Florida, United States
Watson Clinic Center for Cancer Care and Research
Lakeland, Florida, United States
Wellstar Cancer Research
Marietta, Georgia, United States
Consultants in Blood Disorders and Cancer
Louisville, Kentucky, United States
Oncology Hematology Care
Cincinnati, Ohio, United States
Associates in Hematology Oncology
Chattanooga, Tennessee, United States
Start Date
November 1, 2006
Primary Completion Date
January 1, 2009
Completion Date
January 1, 2009
Last Updated
November 9, 2021
NCT06043817
NCT07177937
NCT05671510
NCT06426511
NCT06498635
NCT06257264
Lead Sponsor
SCRI Development Innovations, LLC
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions